featured
CV Risk With Ranibizumab for Wet AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Risk in Patients Receiving Ranibizumab for Exudative Age-Related Macular Degeneration: A Nationwide Self-Controlled Case-Series Study
Br J Ophthalmol 2020 Jun 10;[EPub Ahead of Print], HL Jeon, SJ Byun, NL Pratt, J Sultana, SJ Park, JY ShinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.